Novo Nordisk A/S et al v. Caraco Pharmaceutical Laboratories, Limited
Case Number:
2:05-cv-40188
Court:
Nature of Suit:
Judge:
Firms
Sectors & Industries:
-
February 25, 2011
Caraco Denied Quick Win On Prandin IP Misuse Claim
A federal judge in Michigan on Thursday refused to analyze Caraco Pharmaceutical Laboratories Ltd.'s contention that Novo Nordisk A/S misused its patent for the diabetes drug Prandin, finding the matter inappropriate to consider in light of pending appeals.
-
January 19, 2011
Judge Finds Novo's Prandin Patent Invalid
A federal judge Wednesday found the patent for Novo Nordisk A/S diabetes drug Prandin invalid because of obviousness and unenforceable due to inequitable conduct, paving the way for Caraco Pharmaceutical Laboratories Ltd. to market a generic version.
-
October 07, 2010
Novo Can't Shake Bid To Invalidate Prandin Patent
A federal judge has rejected a bid by Novo Nordisk A/S to dismiss a five-year-old dispute with generics makers Sun Pharmaceutical Industries Ltd. and Caraco Pharmaceutical Laboratories Ltd. over the validity of a patent for diabetes drug Prandin.